Assessment of the cellular internalization of thermolytic phosphorothioate DNA oligonucleotide prodrugs
The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 21; no. 20; pp. 6224 - 6232 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
15.10.2013
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5′-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50μM over a period of 72h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications. |
---|---|
AbstractList | The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5′-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50μM over a period of 72h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications. The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5'-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50 μM over a period of 72 h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications. The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino) ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5'-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N, N-dimethylamino) prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50 mu M over a period of 72 h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N, N-dimethylamino) prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications. Published by Elsevier Ltd. The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5'-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50 mu M over a period of 72 h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications. |
Author | Beaucage, Serge L. Verthelyi, Daniela Tami, Cecilia Jain, Harsh V. Takeda, Kazuyo |
Author_xml | – sequence: 1 givenname: Harsh V. surname: Jain fullname: Jain, Harsh V. organization: Laboratory of Chemistry, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA – sequence: 2 givenname: Kazuyo surname: Takeda fullname: Takeda, Kazuyo organization: Confocal Microscopy Core Facility, FDA-CBER, 8800 Rockville Pike, Bethesda, MD 20892, USA – sequence: 3 givenname: Cecilia surname: Tami fullname: Tami, Cecilia organization: Laboratory of Immunology, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA – sequence: 4 givenname: Daniela surname: Verthelyi fullname: Verthelyi, Daniela organization: Laboratory of Immunology, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA – sequence: 5 givenname: Serge L. surname: Beaucage fullname: Beaucage, Serge L. email: serge.beaucage@fda.hhs.gov organization: Laboratory of Chemistry, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23755885$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUuP0zAUhS00iOkM_AA2kCUSSvEzscWqKk9pBAuYteU4162rJC62Axp-PS4pswQWlm3d7xz73nOFLqYwAUJPCV4TTJpXh3U32jXFhK0xX-OWPEArwhteM6bIBVph1cgaS9VcoquUDhhjyhV5hC4pa4WQUqzQbpMSpDTClKvgqryHysIwzIOJlZ8yxMkM_qfJPkznehzDcJe9rY77kMqKIe99MBmqN582VRj8LkyzHSBk30N1jKGP8y49Rg-dGRI8Oe_X6Pbd26_bD_XN5_cft5ub2vK2yTWYninata0kQnQdl9TwVsjeNapjLekIZcS0DsrFYdpJ46xSpnHOQit4D-wavVh8y8PfZkhZjz6dOjIThDlpIihmUjHO_40WhknZKFxQsqA2hpQiOH2MfjTxThOsT1Hogy5R6FMUGnNdoiiaZ2f7uRuhv1f8mX0B5AL8gC64ZD1MFu6xEhajgjS0HDBRW59_h7AN85SL9OX_Swv9fKGdCdrsok_69kv5qihVQhg7jeL1QkCJ5ruHqM-evY9gs-6D_0unvwAjDscw |
CitedBy_id | crossref_primary_10_1016_j_bmcl_2015_03_064 crossref_primary_10_1021_acs_orglett_8b03501 crossref_primary_10_3762_bjoc_14_32 crossref_primary_10_1002_cbic_201402382 crossref_primary_10_1016_j_bmc_2015_07_054 crossref_primary_10_1039_C5RA12038A crossref_primary_10_1002_cpnc_51 crossref_primary_10_1002_0471142700_nc0469s64 crossref_primary_10_1016_j_bmcl_2015_11_064 crossref_primary_10_1248_cpb_c17_00696 crossref_primary_10_1021_acs_bioconjchem_6b00368 |
Cites_doi | 10.1002/anie.200500904 10.1021/jo062087y 10.1016/j.addr.2007.10.016 10.1021/bc049977+ 10.1021/ar200131t 10.1016/j.chembiol.2012.07.011 10.1517/17425247.2011.561313 10.1007/s00018-009-0186-0 10.1002/cyto.a.20139 10.1093/nar/gki657 10.1046/j.1432-1033.2003.03555.x 10.1007/s10709-009-9405-8 10.1002/path.2993 10.1124/pr.58.1.8 10.1093/nar/gkg733 10.1021/mp900093r 10.1002/cbic.200500433 10.1089/108729002753670247 10.1021/ol0156852 10.3109/08982109709035481 10.1038/78523 10.1016/0960-894X(95)00074-4 10.1073/pnas.97.24.13003 10.1089/108729002760070849 10.1093/nar/27.20.4071 10.1016/S0169-409X(99)00034-4 10.1021/bc0000334 10.4161/cbt.1.4.4 10.2174/1389201043376706 10.1146/annurev.pharmtox.41.1.403 10.1074/jbc.270.52.31391 10.1089/108729002760070795 10.1093/nar/22.20.4268 10.4049/jimmunol.162.4.2291 10.1016/S0005-2736(97)00194-6 10.1248/bpb.28.886 10.1034/j.1399-3011.2000.00723.x |
ContentType | Journal Article |
Copyright | 2013 Published by Elsevier Ltd. |
Copyright_xml | – notice: 2013 – notice: Published by Elsevier Ltd. |
DBID | FBQ 1KM BLEPL DTL GKMDS CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7QO 7TM 8FD FR3 P64 |
DOI | 10.1016/j.bmc.2013.04.071 |
DatabaseName | AGRIS Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science - Science Citation Index Expanded - 2013 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Biotechnology Research Abstracts Nucleic Acids Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Nucleic Acids Abstracts Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE MEDLINE - Academic Web of Science Engineering Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1464-3391 |
EndPage | 6232 |
ExternalDocumentID | 10_1016_j_bmc_2013_04_071 23755885 000325162000019 US201500111334 S0968089613004100 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: Postgraduate Research Participation Program at the Center for Drug Evaluation and Research |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM LCYCR LZ2 M29 M2Z M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPC SPCBC SSH SSK SSP SSU SSZ T5K UPT XPP YK3 ~02 ~G- 53G AAQXK ABPIF ABPTK ACNNM ADMUD AFFNX AGHFR AGRDE ASPBG AVWKF AZFZN FBQ FEDTE FGOYB G-2 HEA HMK HMO HMS HMT HVGLF HZ~ R2- SAE SCB SEW SOC SPT WUQ ZMT 1KM AAXKI AKRWK BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7QO 7TM 8FD FR3 P64 |
ID | FETCH-LOGICAL-c476t-ead392b778155bb482a4758df69b371b1231a7feb37f02b8afc99a6ffce754de3 |
IEDL.DBID | .~1 |
ISICitedReferencesCount | 9 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000325162000019 |
ISSN | 0968-0896 |
IngestDate | Fri Aug 16 22:47:35 EDT 2024 Fri Aug 16 22:40:21 EDT 2024 Thu Sep 12 16:48:13 EDT 2024 Thu May 23 23:17:06 EDT 2024 Wed Sep 18 06:48:42 EDT 2024 Wed Sep 18 03:38:29 EDT 2024 Wed Dec 27 19:01:14 EST 2023 Fri Feb 23 02:30:56 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 20 |
Keywords | Thermolytic DNA prodrugs Nucleic acid-based drug delivery fma-Thiophosphate protecting group Nuclear localization Cellular internalization Positively charged DNA prodrug TRANSPORTERS TRAFFICKING MECHANISMS BIOLOGICAL BARRIERS DELIVERY LIPOPHILIC PRO-OLIGONUCLEOTIDES PROTECTING GROUP HELA-CELLS ANTISENSE OLIGONUCLEOTIDES BACTERIAL-DNA |
Language | English |
License | Published by Elsevier Ltd. |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c476t-ead392b778155bb482a4758df69b371b1231a7feb37f02b8afc99a6ffce754de3 |
Notes | http://dx.doi.org/10.1016/j.bmc.2013.04.071 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ORCID | 0000-0001-8163-6219 |
PMID | 23755885 |
PQID | 1443388690 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1520389344 webofscience_primary_000325162000019CitationCount fao_agris_US201500111334 crossref_primary_10_1016_j_bmc_2013_04_071 elsevier_sciencedirect_doi_10_1016_j_bmc_2013_04_071 proquest_miscellaneous_1443388690 pubmed_primary_23755885 webofscience_primary_000325162000019 |
PublicationCentury | 2000 |
PublicationDate | 2013-10-15 |
PublicationDateYYYYMMDD | 2013-10-15 |
PublicationDate_xml | – month: 10 year: 2013 text: 2013-10-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | OXFORD |
PublicationPlace_xml | – name: OXFORD – name: England |
PublicationTitle | Bioorganic & medicinal chemistry |
PublicationTitleAbbrev | BIOORGAN MED CHEM |
PublicationTitleAlternate | Bioorg Med Chem |
PublicationYear | 2013 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Luo, Saltzman (b0050) 2000; 18 Grajkowski, Ausín, Kauffman, Snyder, Hess, Lloyd, Beaucage (b0170) 2007; 72 Barber, Rayner, Imbach (b0100) 1995; 5 Tung, Stein (b0065) 2000; 11 Guy-Caffey, Bodepudi, Bishop, Jayaraman, Chaudhary (b0140) 1995; 270 Tonkinson, Stein (b0150) 1994; 22 Arora, Devi, Iversen (b0160) 2004; 5 Juliano, Bauman, Kang, Ming (b0035) 2009; 6 Wender, Galliher, Goun, Jones, Pillow (b0070) 2008; 60 Wender, Mitchell, Pattabiraman, Pelkey, Steinman, Rothbard (b0075) 2000; 97 Ohmichi, Kuwahara, Sasaki, Hasegawa, Nishikata, Sawai, Sugimoto (b0080) 2005; 44 Nuutila, Lilius (b0145) 2005; 65A Hemmi, Takeuchi, Kawai, Kaisho, Sato, Sanjo, Matsumoto, Hoshino, Wagner, Takeda, Akira (b0130) 2000; 408 Elkins, Rhinehart-Jones, Stibitz, Conover, Klinman (b0125) 1999; 162 Prater, Miller (b0060) 2004; 15 Manoharan (b0095) 2002; 12 Said Hassane, Saleh, Abes, Gait, Lebleu (b0055) 2010; 67 Vivès, Dell’Aquila, Bologna, Morvan, Rayner, Imbach (b0110) 1999; 27 Li, Frederiksen, Piccirilli (b0045) 2011; 44 Lebedeva, Stein (b0040) 2001; 41 Nishimura, Naito (b0135) 2005; 28 Koppelhus, Awasthi, Zachar, Holst, Ebbesen, Nielsen (b0155) 2002; 12 Michel, Martinand-Maril, Debart, Lebleu, Robbins, Vasseur (b0090) 2003; 31 Khalil, Kogure, Akita, Harashima (b0020) 2006; 58 Mitchell, Kim, Steinman, Fathman, Rothbard (b0175) 2000; 56 Deglane, Abes, Michel, Prévot, Vives, Debart, Barvik, Lebleu, Vasseur (b0085) 2006; 7 Kurreck (b0015) 2003; 270 Dias, Stein (b0165) 2002; 1 Watts, Corey (b0010) 2012; 226 Ming (b0025) 2011; 8 Grajkowski, Wilk, Chmielewski, Phillips, Beaucage (b0115) 2001; 3 Deleavey, Damha (b0005) 2012; 19 Labas, Beilvert, Barteau, David, Chèvre, Pitard (b0185) 2010; 138 Bologna, Vivès, Imbach, Morvan (b0105) 2002; 12 Grajkowski, Pedras-Vasconcelos, Wang, Ausín, Hess, Verthelyi, Beaucage (b0120) 2005; 33 Bally, Harvie, Wong, Kong, Wasan, Reimer (b0030) 1999; 38 Escriou, Ciolina, Lacroix, Byk, Scherman, Wils (b0180) 1998; 1368 Litzinger (b0190) 1997; 7 Grajkowski, A (WOS:000168395400011) 2001; 3 Manoharan, M (WOS:000176064800006) 2002; 12 Watts, JK (WOS:000299157600018) 2012; 226 Deglane, G (WOS:000236685900019) 2006; 7 Litzinger, David C. (BCI:BCI199799461657) 1997; 7 Vives, E (WOS:000083201400015) 1999; 27 Ming, X (WOS:000288549600004) 2011; 8 Nishimura, M (WOS:000229083600023) 2005; 28 Khalil, IA (WOS:000235683400005) 2006; 58 Bally, MB (WOS:000082371300007) 1999; 38 Bologna, JC (WOS:000175215800004) 2002; 12 GuyCaffey, JK (WOS:A1995TN44400080) 1995; 270 Grajkowski, A (WOS:000230345800017) 2005; 33 Luo, D (WOS:000084699900021) 2000; 18 Juliano, R (WOS:000266652600005) 2009; 6 Deleavey, GF (WOS:000309152500006) 2012; 19 Wender, PA (WOS:000254068000003) 2008; 60 Koppelhus, U (WOS:000176064800001) 2002; 12 Escriou, V (WOS:000071507800012) 1998; 1368 Li, NS (WOS:000298575400003) 2011; 44 Hemmi, H (WOS:000165815200054) 2000; 408 Arora, V (WOS:000224302900005) 2004; 5 Dias, N (WOS:000178737000007) 2002; 1 BARBER, I (WOS:A1995QN51900007) 1995; 5 Nuutila, J (WOS:000229353200001) 2005; 65A Labas, R (WOS:000273084000001) 2010; 138 Hassane, FS (WOS:000274655600004) 2010; 67 Elkins, KL (WOS:000078510800054) 1999; 162 Michel, T (WOS:000185353200008) 2003; 31 Grajkowski, A (WOS:000243735500017) 2007; 72 Mitchell, DJ (WOS:000165173900006) 2000; 56 Prater, CE (WOS:000221563300009) 2004; 15 TONKINSON, JL (WOS:A1994PQ22000035) 1994; 22 Lebedeva, I (WOS:000168439400016) 2001; 41 Wender, PA (WOS:000165476300022) 2000; 97 Ohmichi, T (WOS:000232958100007) 2005; 44 Kurreck, J (WOS:000182118800003) 2003; 270 Tung, CH (WOS:000089558300001) 2000; 11 Barber (10.1016/j.bmc.2013.04.071_b0100) 1995; 5 Watts (10.1016/j.bmc.2013.04.071_b0010) 2012; 226 Michel (10.1016/j.bmc.2013.04.071_b0090) 2003; 31 Deglane (10.1016/j.bmc.2013.04.071_b0085) 2006; 7 Arora (10.1016/j.bmc.2013.04.071_b0160) 2004; 5 Guy-Caffey (10.1016/j.bmc.2013.04.071_b0140) 1995; 270 Prater (10.1016/j.bmc.2013.04.071_b0060) 2004; 15 Manoharan (10.1016/j.bmc.2013.04.071_b0095) 2002; 12 Juliano (10.1016/j.bmc.2013.04.071_b0035) 2009; 6 Elkins (10.1016/j.bmc.2013.04.071_b0125) 1999; 162 Nuutila (10.1016/j.bmc.2013.04.071_b0145) 2005; 65A Tonkinson (10.1016/j.bmc.2013.04.071_b0150) 1994; 22 Wender (10.1016/j.bmc.2013.04.071_b0075) 2000; 97 Mitchell (10.1016/j.bmc.2013.04.071_b0175) 2000; 56 Khalil (10.1016/j.bmc.2013.04.071_b0020) 2006; 58 Bally (10.1016/j.bmc.2013.04.071_b0030) 1999; 38 Grajkowski (10.1016/j.bmc.2013.04.071_b0115) 2001; 3 Said Hassane (10.1016/j.bmc.2013.04.071_b0055) 2010; 67 Escriou (10.1016/j.bmc.2013.04.071_b0180) 1998; 1368 Bologna (10.1016/j.bmc.2013.04.071_b0105) 2002; 12 Grajkowski (10.1016/j.bmc.2013.04.071_b0120) 2005; 33 Li (10.1016/j.bmc.2013.04.071_b0045) 2011; 44 Vivès (10.1016/j.bmc.2013.04.071_b0110) 1999; 27 Grajkowski (10.1016/j.bmc.2013.04.071_b0170) 2007; 72 Lebedeva (10.1016/j.bmc.2013.04.071_b0040) 2001; 41 Hemmi (10.1016/j.bmc.2013.04.071_b0130) 2000; 408 Luo (10.1016/j.bmc.2013.04.071_b0050) 2000; 18 Kurreck (10.1016/j.bmc.2013.04.071_b0015) 2003; 270 Nishimura (10.1016/j.bmc.2013.04.071_b0135) 2005; 28 Ming (10.1016/j.bmc.2013.04.071_b0025) 2011; 8 Deleavey (10.1016/j.bmc.2013.04.071_b0005) 2012; 19 Ohmichi (10.1016/j.bmc.2013.04.071_b0080) 2005; 44 Koppelhus (10.1016/j.bmc.2013.04.071_b0155) 2002; 12 Wender (10.1016/j.bmc.2013.04.071_b0070) 2008; 60 Tung (10.1016/j.bmc.2013.04.071_b0065) 2000; 11 Litzinger (10.1016/j.bmc.2013.04.071_b0190) 1997; 7 Dias (10.1016/j.bmc.2013.04.071_b0165) 2002; 1 Labas (10.1016/j.bmc.2013.04.071_b0185) 2010; 138 |
References_xml | – volume: 38 start-page: 291 year: 1999 ident: b0030 contributor: fullname: Reimer – volume: 31 start-page: 5282 year: 2003 ident: b0090 publication-title: Nucleic Acids Res. contributor: fullname: Vasseur – volume: 27 start-page: 4071 year: 1999 ident: b0110 publication-title: Nucleic Acids Res. contributor: fullname: Imbach – volume: 8 start-page: 435 year: 2011 ident: b0025 publication-title: Expert Opin. Drug Deliv. contributor: fullname: Ming – volume: 97 start-page: 13003 year: 2000 ident: b0075 publication-title: Proc. Natl. Acad. Sci. U.S.A. contributor: fullname: Rothbard – volume: 3 start-page: 1287 year: 2001 ident: b0115 publication-title: Org. Lett. contributor: fullname: Beaucage – volume: 1368 start-page: 276 year: 1998 ident: b0180 publication-title: Biochim. Biophys. Acta contributor: fullname: Wils – volume: 12 start-page: 51 year: 2002 ident: b0155 publication-title: . contributor: fullname: Nielsen – volume: 56 start-page: 318 year: 2000 ident: b0175 publication-title: J. Pept. Res. contributor: fullname: Rothbard – volume: 60 start-page: 452 year: 2008 ident: b0070 publication-title: Adv. Drug Delivery Rev. contributor: fullname: Pillow – volume: 22 start-page: 4268 year: 1994 ident: b0150 publication-title: . contributor: fullname: Stein – volume: 138 start-page: 153 year: 2010 ident: b0185 publication-title: Genetica contributor: fullname: Pitard – volume: 65A start-page: 93 year: 2005 ident: b0145 publication-title: Cytometry Part A contributor: fullname: Lilius – volume: 162 start-page: 2291 year: 1999 ident: b0125 publication-title: J. Immunol. contributor: fullname: Klinman – volume: 12 start-page: 33 year: 2002 ident: b0105 publication-title: . contributor: fullname: Morvan – volume: 7 start-page: 684 year: 2006 ident: b0085 publication-title: ChemBioChem contributor: fullname: Vasseur – volume: 270 start-page: 1628 year: 2003 ident: b0015 publication-title: . contributor: fullname: Kurreck – volume: 11 start-page: 605 year: 2000 ident: b0065 publication-title: Bioconjugate Chem. contributor: fullname: Stein – volume: 5 start-page: 431 year: 2004 ident: b0160 publication-title: . contributor: fullname: Iversen – volume: 28 start-page: 886 year: 2005 ident: b0135 publication-title: . contributor: fullname: Naito – volume: 12 start-page: 103 year: 2002 ident: b0095 publication-title: Antisense Nucleic Acid Drug Dev. contributor: fullname: Manoharan – volume: 41 start-page: 403 year: 2001 ident: b0040 publication-title: Annu. Rev. Pharmacol. contributor: fullname: Stein – volume: 44 start-page: 6682 year: 2005 ident: b0080 publication-title: Angew. Chem., Int. Ed. contributor: fullname: Sugimoto – volume: 15 start-page: 498 year: 2004 ident: b0060 publication-title: Bioconjugate Chem. contributor: fullname: Miller – volume: 33 start-page: 3550 year: 2005 ident: b0120 publication-title: . contributor: fullname: Beaucage – volume: 226 start-page: 365 year: 2012 ident: b0010 publication-title: J. Pathol. contributor: fullname: Corey – volume: 19 start-page: 937 year: 2012 ident: b0005 publication-title: Chem. Biol. contributor: fullname: Damha – volume: 18 start-page: 33 year: 2000 ident: b0050 contributor: fullname: Saltzman – volume: 67 start-page: 715 year: 2010 ident: b0055 publication-title: Cell. Mol. Life Sci. contributor: fullname: Lebleu – volume: 1 start-page: 347 year: 2002 ident: b0165 publication-title: Mol. Cancer Ther. contributor: fullname: Stein – volume: 72 start-page: 805 year: 2007 ident: b0170 publication-title: J. Org. Chem. contributor: fullname: Beaucage – volume: 408 start-page: 740 year: 2000 ident: b0130 publication-title: Nat. Biotechnol. contributor: fullname: Akira – volume: 5 start-page: 563 year: 1995 ident: b0100 publication-title: . contributor: fullname: Imbach – volume: 58 start-page: 32 year: 2006 ident: b0020 publication-title: Pharmacol. Rev. contributor: fullname: Harashima – volume: 270 start-page: 31391 year: 1995 ident: b0140 publication-title: J. Biol. Chem. contributor: fullname: Chaudhary – volume: 7 start-page: 51 year: 1997 ident: b0190 publication-title: J. Liposome Res. contributor: fullname: Litzinger – volume: 6 start-page: 686 year: 2009 ident: b0035 publication-title: Mol. Pharm. contributor: fullname: Ming – volume: 44 start-page: 1257 year: 2011 ident: b0045 publication-title: Acc. Chem. Res. contributor: fullname: Piccirilli – volume: 44 start-page: 6682 year: 2005 ident: WOS:000232958100007 article-title: Nucleic acid with guanidinium modification exhibits efficient cellular uptake publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.200500904 contributor: fullname: Ohmichi, T – volume: 72 start-page: 805 year: 2007 ident: WOS:000243735500017 article-title: Solid-phase synthesis of thermolytic DNA oligonucleotides functionalized with a single 4-hydroxy-1-butyl or 4-phosphato-/thiophosphato-1-butyl thiophosphate protecting group publication-title: JOURNAL OF ORGANIC CHEMISTRY doi: 10.1021/jo062087y contributor: fullname: Grajkowski, A – volume: 1 start-page: 347 year: 2002 ident: WOS:000178737000007 article-title: Antisense oligonucleotides: Basic concepts and mechanisms publication-title: MOLECULAR CANCER THERAPEUTICS contributor: fullname: Dias, N – volume: 11 start-page: 605 year: 2000 ident: WOS:000089558300001 article-title: Preparation and applications of peptide-oligonucleotide conjugates publication-title: BIOCONJUGATE CHEMISTRY contributor: fullname: Tung, CH – volume: 60 start-page: 452 year: 2008 ident: WOS:000254068000003 article-title: The design of guanidinium-rich transporters and their internalization mechanisms publication-title: ADVANCED DRUG DELIVERY REVIEWS doi: 10.1016/j.addr.2007.10.016 contributor: fullname: Wender, PA – volume: 408 start-page: 740 year: 2000 ident: WOS:000165815200054 article-title: A Toll-like receptor recognizes bacterial DNA publication-title: NATURE contributor: fullname: Hemmi, H – volume: 15 start-page: 498 year: 2004 ident: WOS:000221563300009 article-title: 3 '-methyphosphate-modified oligo-2 '-O-methylribonucleotides and their tat peptide conjugates: Uptake and stability in mouse fibroblasts in culture publication-title: BIOCONJUGATE CHEMISTRY doi: 10.1021/bc049977+ contributor: fullname: Prater, CE – volume: 3 start-page: 1287 year: 2001 ident: WOS:000168395400011 article-title: The 2-(N-formyl-N-methyl)aminoethyl group as a potential phosphate/thiophosphate protecting group in solid-phase oligodeoxyribonucleotide synthesis publication-title: ORGANIC LETTERS contributor: fullname: Grajkowski, A – volume: 44 start-page: 1257 year: 2011 ident: WOS:000298575400003 article-title: Synthesis, Properties, and Applications of Oligonucleotides Containing an RNA Dinucleotide Phosphorothiolate Linkage publication-title: ACCOUNTS OF CHEMICAL RESEARCH doi: 10.1021/ar200131t contributor: fullname: Li, NS – volume: 270 start-page: 31391 year: 1995 ident: WOS:A1995TN44400080 article-title: Novel polyaminolipids enhance the cellular uptake of oligonucleotides publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY contributor: fullname: GuyCaffey, JK – volume: 19 start-page: 937 year: 2012 ident: WOS:000309152500006 article-title: Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing publication-title: CHEMISTRY & BIOLOGY doi: 10.1016/j.chembiol.2012.07.011 contributor: fullname: Deleavey, GF – volume: 8 start-page: 435 year: 2011 ident: WOS:000288549600004 article-title: Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis publication-title: EXPERT OPINION ON DRUG DELIVERY doi: 10.1517/17425247.2011.561313 contributor: fullname: Ming, X – volume: 67 start-page: 715 year: 2010 ident: WOS:000274655600004 article-title: Cell penetrating peptides: overview and applications to the delivery of oligonucleotides publication-title: CELLULAR AND MOLECULAR LIFE SCIENCES doi: 10.1007/s00018-009-0186-0 contributor: fullname: Hassane, FS – volume: 56 start-page: 318 year: 2000 ident: WOS:000165173900006 article-title: Polyarginine enters cells more efficiently than other polycationic homopolymers publication-title: JOURNAL OF PEPTIDE RESEARCH contributor: fullname: Mitchell, DJ – volume: 22 start-page: 4268 year: 1994 ident: WOS:A1994PQ22000035 article-title: PATTERNS OF INTRACELLULAR COMPARTMENTALIZATION, TRAFFICKING AND ACIDIFICATION OF 5'-FLUORESCEIN LABELED PHOSPHODIESTER AND PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES IN HL-60 CELLS publication-title: NUCLEIC ACIDS RESEARCH contributor: fullname: TONKINSON, JL – volume: 28 start-page: 886 year: 2005 ident: WOS:000229083600023 article-title: Tissue-specific mRNA expression profiles of human toll-like receptors and related genes publication-title: BIOLOGICAL & PHARMACEUTICAL BULLETIN contributor: fullname: Nishimura, M – volume: 12 start-page: 51 year: 2002 ident: WOS:000176064800001 article-title: Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates publication-title: ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT contributor: fullname: Koppelhus, U – volume: 41 start-page: 403 year: 2001 ident: WOS:000168439400016 article-title: Antisense oligonucleotides: Promise and reality publication-title: ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY contributor: fullname: Lebedeva, I – volume: 7 start-page: 51 year: 1997 ident: BCI:BCI199799461657 article-title: Limitations of cationic liposomes for antisense oligonucleotide delivery in vivo publication-title: Journal of Liposome Research contributor: fullname: Litzinger, David C. – volume: 18 start-page: 33 year: 2000 ident: WOS:000084699900021 article-title: Synthetic DNA delivery systems publication-title: NATURE BIOTECHNOLOGY contributor: fullname: Luo, D – volume: 12 start-page: 33 year: 2002 ident: WOS:000175215800004 article-title: Uptake and quantification of intracellular concentration of lipophilic pro-oligonucleotides in HeLa cells publication-title: ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT contributor: fullname: Bologna, JC – volume: 65A start-page: 93 year: 2005 ident: WOS:000229353200001 article-title: Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells publication-title: CYTOMETRY PART A doi: 10.1002/cyto.a.20139 contributor: fullname: Nuutila, J – volume: 1368 start-page: 276 year: 1998 ident: WOS:000071507800012 article-title: Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes publication-title: BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES contributor: fullname: Escriou, V – volume: 33 start-page: 3550 year: 2005 ident: WOS:000230345800017 article-title: Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs publication-title: NUCLEIC ACIDS RESEARCH doi: 10.1093/nar/gki657 contributor: fullname: Grajkowski, A – volume: 38 start-page: 291 year: 1999 ident: WOS:000082371300007 article-title: Biological barriers to cellular delivery of lipid-based DNA carriers publication-title: ADVANCED DRUG DELIVERY REVIEWS contributor: fullname: Bally, MB – volume: 162 start-page: 2291 year: 1999 ident: WOS:000078510800054 article-title: Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria publication-title: JOURNAL OF IMMUNOLOGY contributor: fullname: Elkins, KL – volume: 5 start-page: 431 year: 2004 ident: WOS:000224302900005 article-title: Neutrally charged phosphorodiamidate morpholino antisense oligomers: Uptake, efficacy and pharmacokinetics publication-title: CURRENT PHARMACEUTICAL BIOTECHNOLOGY contributor: fullname: Arora, V – volume: 27 start-page: 4071 year: 1999 ident: WOS:000083201400015 article-title: Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells publication-title: NUCLEIC ACIDS RESEARCH contributor: fullname: Vives, E – volume: 270 start-page: 1628 year: 2003 ident: WOS:000182118800003 article-title: Antisense technologies - Improvement through novel chemical modifications publication-title: EUROPEAN JOURNAL OF BIOCHEMISTRY doi: 10.1046/j.1432-1033.2003.03555.x contributor: fullname: Kurreck, J – volume: 12 start-page: 103 year: 2002 ident: WOS:000176064800006 article-title: Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action publication-title: ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT contributor: fullname: Manoharan, M – volume: 138 start-page: 153 year: 2010 ident: WOS:000273084000001 article-title: Nature as a source of inspiration for cationic lipid synthesis publication-title: GENETICA doi: 10.1007/s10709-009-9405-8 contributor: fullname: Labas, R – volume: 226 start-page: 365 year: 2012 ident: WOS:000299157600018 article-title: Silencing disease genes in the laboratory and the clinic publication-title: JOURNAL OF PATHOLOGY doi: 10.1002/path.2993 contributor: fullname: Watts, JK – volume: 97 start-page: 13003 year: 2000 ident: WOS:000165476300022 article-title: The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA contributor: fullname: Wender, PA – volume: 58 start-page: 32 year: 2006 ident: WOS:000235683400005 article-title: Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery publication-title: PHARMACOLOGICAL REVIEWS doi: 10.1124/pr.58.1.8 contributor: fullname: Khalil, IA – volume: 31 start-page: 5282 year: 2003 ident: WOS:000185353200008 article-title: Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation publication-title: NUCLEIC ACIDS RESEARCH doi: 10.1093/nar/gkg733 contributor: fullname: Michel, T – volume: 5 start-page: 563 year: 1995 ident: WOS:A1995QN51900007 article-title: THE PROOLIGONUCLEOTIDE APPROACH .1. ESTERASE-MEDIATED REVERSIBILITY OF DITHYMIDINE-S-ALKYL-PHOSPHOROTHIOLATES TO DITHYMIDINE PHOSPHOROTHIOATES publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS contributor: fullname: BARBER, I – volume: 6 start-page: 686 year: 2009 ident: WOS:000266652600005 article-title: Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides publication-title: MOLECULAR PHARMACEUTICS doi: 10.1021/mp900093r contributor: fullname: Juliano, R – volume: 7 start-page: 684 year: 2006 ident: WOS:000236685900019 article-title: Impact of the guanidinium group on hybridization and cellular uptake of cationic oligonucleotides publication-title: CHEMBIOCHEM doi: 10.1002/cbic.200500433 contributor: fullname: Deglane, G – volume: 7 start-page: 684 year: 2006 ident: 10.1016/j.bmc.2013.04.071_b0085 publication-title: ChemBioChem doi: 10.1002/cbic.200500433 contributor: fullname: Deglane – volume: 12 start-page: 33 year: 2002 ident: 10.1016/j.bmc.2013.04.071_b0105 publication-title: Antisense Nucleic Acid Drug Dev. doi: 10.1089/108729002753670247 contributor: fullname: Bologna – volume: 3 start-page: 1287 year: 2001 ident: 10.1016/j.bmc.2013.04.071_b0115 publication-title: Org. Lett. doi: 10.1021/ol0156852 contributor: fullname: Grajkowski – volume: 7 start-page: 51 year: 1997 ident: 10.1016/j.bmc.2013.04.071_b0190 publication-title: J. Liposome Res. doi: 10.3109/08982109709035481 contributor: fullname: Litzinger – volume: 18 start-page: 33 year: 2000 ident: 10.1016/j.bmc.2013.04.071_b0050 publication-title: Nat. Biotechnol. doi: 10.1038/78523 contributor: fullname: Luo – volume: 33 start-page: 3550 year: 2005 ident: 10.1016/j.bmc.2013.04.071_b0120 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gki657 contributor: fullname: Grajkowski – volume: 8 start-page: 435 year: 2011 ident: 10.1016/j.bmc.2013.04.071_b0025 publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2011.561313 contributor: fullname: Ming – volume: 5 start-page: 563 year: 1995 ident: 10.1016/j.bmc.2013.04.071_b0100 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/0960-894X(95)00074-4 contributor: fullname: Barber – volume: 226 start-page: 365 year: 2012 ident: 10.1016/j.bmc.2013.04.071_b0010 publication-title: J. Pathol. doi: 10.1002/path.2993 contributor: fullname: Watts – volume: 97 start-page: 13003 year: 2000 ident: 10.1016/j.bmc.2013.04.071_b0075 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.97.24.13003 contributor: fullname: Wender – volume: 12 start-page: 103 year: 2002 ident: 10.1016/j.bmc.2013.04.071_b0095 publication-title: Antisense Nucleic Acid Drug Dev. doi: 10.1089/108729002760070849 contributor: fullname: Manoharan – volume: 44 start-page: 1257 year: 2011 ident: 10.1016/j.bmc.2013.04.071_b0045 publication-title: Acc. Chem. Res. doi: 10.1021/ar200131t contributor: fullname: Li – volume: 27 start-page: 4071 year: 1999 ident: 10.1016/j.bmc.2013.04.071_b0110 publication-title: Nucleic Acids Res. doi: 10.1093/nar/27.20.4071 contributor: fullname: Vivès – volume: 31 start-page: 5282 year: 2003 ident: 10.1016/j.bmc.2013.04.071_b0090 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkg733 contributor: fullname: Michel – volume: 38 start-page: 291 year: 1999 ident: 10.1016/j.bmc.2013.04.071_b0030 publication-title: Adv. Drug Delivery Rev. doi: 10.1016/S0169-409X(99)00034-4 contributor: fullname: Bally – volume: 19 start-page: 937 year: 2012 ident: 10.1016/j.bmc.2013.04.071_b0005 publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2012.07.011 contributor: fullname: Deleavey – volume: 58 start-page: 32 year: 2006 ident: 10.1016/j.bmc.2013.04.071_b0020 publication-title: Pharmacol. Rev. doi: 10.1124/pr.58.1.8 contributor: fullname: Khalil – volume: 6 start-page: 686 year: 2009 ident: 10.1016/j.bmc.2013.04.071_b0035 publication-title: Mol. Pharm. doi: 10.1021/mp900093r contributor: fullname: Juliano – volume: 11 start-page: 605 year: 2000 ident: 10.1016/j.bmc.2013.04.071_b0065 publication-title: Bioconjugate Chem. doi: 10.1021/bc0000334 contributor: fullname: Tung – volume: 1 start-page: 347 year: 2002 ident: 10.1016/j.bmc.2013.04.071_b0165 publication-title: Mol. Cancer Ther. doi: 10.4161/cbt.1.4.4 contributor: fullname: Dias – volume: 60 start-page: 452 year: 2008 ident: 10.1016/j.bmc.2013.04.071_b0070 publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2007.10.016 contributor: fullname: Wender – volume: 5 start-page: 431 year: 2004 ident: 10.1016/j.bmc.2013.04.071_b0160 publication-title: Curr. Pharm. Biotechnol. doi: 10.2174/1389201043376706 contributor: fullname: Arora – volume: 41 start-page: 403 year: 2001 ident: 10.1016/j.bmc.2013.04.071_b0040 publication-title: Annu. Rev. Pharmacol. doi: 10.1146/annurev.pharmtox.41.1.403 contributor: fullname: Lebedeva – volume: 270 start-page: 31391 year: 1995 ident: 10.1016/j.bmc.2013.04.071_b0140 publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.52.31391 contributor: fullname: Guy-Caffey – volume: 12 start-page: 51 year: 2002 ident: 10.1016/j.bmc.2013.04.071_b0155 publication-title: Antisense Nucleic Acid Drug Dev. doi: 10.1089/108729002760070795 contributor: fullname: Koppelhus – volume: 22 start-page: 4268 year: 1994 ident: 10.1016/j.bmc.2013.04.071_b0150 publication-title: Nucleic Acids Res. doi: 10.1093/nar/22.20.4268 contributor: fullname: Tonkinson – volume: 408 start-page: 740 year: 2000 ident: 10.1016/j.bmc.2013.04.071_b0130 publication-title: Nat. Biotechnol. contributor: fullname: Hemmi – volume: 270 start-page: 1628 year: 2003 ident: 10.1016/j.bmc.2013.04.071_b0015 publication-title: Eur. J. Biochem. doi: 10.1046/j.1432-1033.2003.03555.x contributor: fullname: Kurreck – volume: 162 start-page: 2291 year: 1999 ident: 10.1016/j.bmc.2013.04.071_b0125 publication-title: J. Immunol. doi: 10.4049/jimmunol.162.4.2291 contributor: fullname: Elkins – volume: 67 start-page: 715 year: 2010 ident: 10.1016/j.bmc.2013.04.071_b0055 publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-009-0186-0 contributor: fullname: Said Hassane – volume: 72 start-page: 805 year: 2007 ident: 10.1016/j.bmc.2013.04.071_b0170 publication-title: J. Org. Chem. doi: 10.1021/jo062087y contributor: fullname: Grajkowski – volume: 138 start-page: 153 year: 2010 ident: 10.1016/j.bmc.2013.04.071_b0185 publication-title: Genetica doi: 10.1007/s10709-009-9405-8 contributor: fullname: Labas – volume: 44 start-page: 6682 year: 2005 ident: 10.1016/j.bmc.2013.04.071_b0080 publication-title: Angew. Chem., Int. Ed. doi: 10.1002/anie.200500904 contributor: fullname: Ohmichi – volume: 1368 start-page: 276 year: 1998 ident: 10.1016/j.bmc.2013.04.071_b0180 publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2736(97)00194-6 contributor: fullname: Escriou – volume: 15 start-page: 498 year: 2004 ident: 10.1016/j.bmc.2013.04.071_b0060 publication-title: Bioconjugate Chem. doi: 10.1021/bc049977+ contributor: fullname: Prater – volume: 28 start-page: 886 year: 2005 ident: 10.1016/j.bmc.2013.04.071_b0135 publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.28.886 contributor: fullname: Nishimura – volume: 65A start-page: 93 year: 2005 ident: 10.1016/j.bmc.2013.04.071_b0145 publication-title: Cytometry Part A doi: 10.1002/cyto.a.20139 contributor: fullname: Nuutila – volume: 56 start-page: 318 year: 2000 ident: 10.1016/j.bmc.2013.04.071_b0175 publication-title: J. Pept. Res. doi: 10.1034/j.1399-3011.2000.00723.x contributor: fullname: Mitchell |
SSID | ssj0002491 |
Score | 2.1891904 |
Snippet | The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice... The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino) ethyl (fma) thiophosphate groups in mice... |
Source | Web of Science |
SourceID | proquest crossref pubmed webofscience fao elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 6224 |
SubjectTerms | Animals Biochemistry & Molecular Biology Cellular internalization Cercopithecus aethiops Chemistry Chemistry, Medicinal Chemistry, Organic cytotoxicity DNA DNA - chemistry DNA - pharmacokinetics drugs flow cytometry Fluoresceins - chemistry fma-Thiophosphate protecting group HeLa Cells Humans Life Sciences & Biomedicine Lipids - chemistry Lipids - pharmacokinetics Mice microscopy Microscopy, Confocal Nuclear localization Nucleic acid-based drug delivery nucleotide sequences oligonucleotides Oligonucleotides - chemistry Oligonucleotides - pharmacokinetics Pharmacology & Pharmacy Physical Sciences Positively charged DNA prodrug Prodrugs - pharmacokinetics Science & Technology Thermolytic DNA prodrugs Thionucleotides - chemistry Thionucleotides - pharmacokinetics thiophosphate Vero Cells |
Title | Assessment of the cellular internalization of thermolytic phosphorothioate DNA oligonucleotide prodrugs |
URI | https://dx.doi.org/10.1016/j.bmc.2013.04.071 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000325162000019 https://www.ncbi.nlm.nih.gov/pubmed/23755885 https://search.proquest.com/docview/1443388690 https://search.proquest.com/docview/1520389344 |
Volume | 21 |
WOS | 000325162000019 |
WOSCitedRecordID | wos000325162000019 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIgEXBClQF6gWqeKAZOLHrtc-WoEqgJpLidTbyuvspkaJN8rj0Au_vTN-BJBKhTjkkHjjJPtNZr5vdnYW4MwkpUliG_mFKClbJbSfZYXxg1midSqlKJtkzsUkGU_51ytxdQCjfi8MlVV2vr_16Y237l4ZdrM5XFXV8BLJdxqkGRHggIcB6XaOwQht-uPPX2UeKC-aU_NwsE-j-5XNpsZLL6mLYRg33U5l-LfY9MAW7i4GemewagLT-TN42jFKlrdf-jkcmHoAR3mNanp5w96zpsazSZ4P4PGoP99tAI8uumX1I5jn-_6czFmGnJBRQp8qVFnVpgwX3X7N7vp66RY3-IFsde02-Fgj4JVD3so-TXLmFtXc1dQp2W2rmWHkpde7-eYFTM8_fx-N_e4EBr_kMtn6aGbIn7SUKdIOrXkaFRwFxswmmY5lqDHshYW0KMilDSKdFrZEpBNrSyMFn5n4JRzWrjbHwHgpaQ9uZEOpkTTERYZWkonS4m1jkyYefOjnXq3aRhuqr0D7oRAoRUCpgCsEygPeo6P-sBaFgeC-tx0jkqqYo_9U08uIsj3o31Cmcw_e9fAqxIEmuaiN221QG3GU8XRw1z1jRESNCmOO93nV2sb-R0SxFCJNhQdnvxvL_jqpUiSZSdQstGQehP8ybNR1cKfOBduT_5uO1_CEnlEkDsUbONyud-YtUqytPm3-Q6fwMP_ybTy5BSlnIxM |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6FFh3KbZ0W929NKDYYYARPyTLPhrZinRtcmkD9CZYjpR6SKwgj0P__ShbDjagK4YdfLHkl0iT30dRFMC5SkqVxDryC1baaBWTfpYVyg9miZQp56xsgjnjSTKa0h937O4Aht1aGJtW6Wx_a9Mba-3ODNxoDlZVNbhB8J0GaWYBcEDDAHn7IWU8pD04zC-vRpO9QUaG0Wych_19e0E3udmkecmlLWQYxk3BUx7-zT0904V5DIQ-6q8a33TxEo4dqCR5-96v4EDVfTjJayTUywfyhTRpnk38vA9Hw26Ltz48H7uZ9ROY5_sSncRogrCQ2Ji-TVIlVRs1XLglm659vTSLB3wgWd2bDR5rlHllELqSb5OcmEU1N7Utlmy21UwRa6jXu_nmNUwvvt8OR77bhMEvKU-2PmoaQijJeYrIQ0qaRgVFjjHTSSZjHkr0fGHBNXJyroNIpoUuUdiJ1qXijM5U_AZ6tanVKRBacrsMN9Ihl4gb4iJDRclYqfG2sUoTD752Yy9Wba0N0SWh_RQoKGEFJQIqUFAe0E464g-FEegLnrrsFCUpijmaUDG9iWzAB00cMnXqwedOvALlYAe5qJXZbZAeUWTydu-uJ_qwyNYqjCne522rG_uPiGLOWJoyD85_V5Z9uyWmiDOTqJlryTwI_6Xb0BVxt8ULtmf_Nxyf4Gh0O74W15eTq3fwwrZYxxyy99DbrnfqAyKurfzo_qhfJRUlyQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+the+cellular+internalization+of+thermolytic+phosphorothioate+DNA+oligonucleotide+prodrugs&rft.jtitle=Bioorganic+%26+medicinal+chemistry&rft.au=Jain%2C+Harsh+V&rft.au=Takeda%2C+Kazuyo&rft.au=Tami%2C+Cecilia&rft.au=Verthelyi%2C+Daniela&rft.date=2013-10-15&rft.pub=Elsevier+Ltd&rft.issn=0968-0896&rft.eissn=1464-3391&rft.volume=21&rft.issue=20&rft.spage=6224&rft.epage=6232&rft_id=info:doi/10.1016%2Fj.bmc.2013.04.071&rft.externalDocID=US201500111334 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0968-0896&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0968-0896&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0968-0896&client=summon |